P -blockers

Two different types of P-adrenoceptors have been characterized and categorized as P - and P2-subtypes. The P -receptors are associated primarily with the cardiac muscle, whereas the P2-subtype is located peripherally. Selective P -blockers include practolol (121) and (122), atenolol (123) and (124), and betaxolol (125) and (126). 

Cromakalim (137) is a potassium channel activator commonly used as an antihypertensive agent (107). The rationale for the design of cromakalim is based on P-blockers such as propranolol (115) and atenolol (123). Conformational restriction of the propanolamine side chain as observed in the cromakalim chroman nucleus provides compounds with desired antihypertensive activity free of the side effects commonly associated with P-blockers. Enantiomerically pure cromakalim is produced by resolution of the diastereomeric (T)-a-meth5lben2ylcarbamate derivatives. X-ray crystallographic analysis of this diastereomer provides the absolute stereochemistry of cromakalim. Biological activity resides primarily in the (—)-(33, 4R)-enantiomer [94535-50-9] (137) (108). In spontaneously hypertensive rats, the (—)-(33, 4R)-enantiomer, at dosages of 0.3 mg/kg, lowers the systoHc pressure 47%, whereas the (+)-(3R,43)-enantiomer only decreases the systoHc pressure by 14% at a dose of 3.0 mg/kg. 

The Diacel columns can be used for the separation of a wide variety of compounds, including aromatic hydrocarbons having hydroxyl groups, carbonyls and sulfoxides, barbiturates, and P-blockers (35,36). There are presendy nine different cellulose derivative-based columns produced by Diacel Chemical Industries. The different columns each demonstrate unique selectivities so that a choice of stationary phases is available to accomplish a separation. 

The use of selective P-antagonists for treatment of CHF has included the P -blocker metoprolol (Table 1) and results of clinical trials suggest long-term beneficial effects. Selective P -antagonists have also been tested, an example of which is xamoterol [81801 -12-9], C2 H25N20, which is (i)-A/-(2-hydroxy-3-(4-hydroxyphenoxy)propylamino)ethylmorphine-4-carboxamide. Xamoterol exhibits approximately 50% of the activity of isoproterenol, and serves to provide modest inotropic effects (128,129). 

The synthetic utihty of the above transformations stems from the fact that many monoesters obtained as a result of hydrolysis may be converted to pharmaceutically important intermediates. For example, the optically active glycerol derivative (27) is a key intermediate in the production of P-blockers. Akyl derivative (25) may be converted into (5)-paraconic acid [4694-66-0] ((5)-5-oxo-3-tetrahydrofurancarboxyhc acid) that is a starting material for the synthesis of (3R)-A-factor. The unsaturated chiral cycHc monoacetate (31) is an optically active synthon for prostaglandins, and the monoester (29) is used for the synthesis of platelet activating factor (PAF) antagonists. 

Both saturated (50) and unsaturated derivatives (51) are easily accepted by lipases and esterases. Lipase P from Amano resolves azide (52) or naphthyl (53) derivatives with good yields and excellent selectivity. PPL-catalyzed resolution of glycidyl esters (54) is of great synthetic utiUty because it provides an alternative to the Sharpless epoxidation route for the synthesis of P-blockers. The optical purity of glycidyl esters strongly depends on the stmcture of the acyl moiety the hydrolysis of propyl and butyl derivatives of epoxy alcohols results ia esters with ee > 95% (30). 

Lipase-catalyzed enantioselective transesterification of 0-substituted-l,2-diols is another practical route for the synthesis of P-blockers. Lipase PS suspended in toluene catalyzes the transesterification of (63) with vinyl acetate to give the (5)-ester in 43% yield and >98% ee (78). The desired product, optically pure (R)-ttitylglycidol, is then easily obtained by treating the ester with alcohoHc alkaU. Moreover, Pseudomonas Hpase catalyzes the acylation of oxazohdinone (64) with acetic anhydride in very good yield and selectivity (74). PPL-catalyzed transesterification of a number of /n j -norbomene derivatives proceeds in about 30% yield and 92% ee (79,80). 

P-Blockers Saturated solution of ammonium monovanadate in cone, sulfuric add [7]. 

Fig. 2-2. The enantiomeric sepai ation of P-blockers on teicoplanin CSP (250 x 4.6 mm) with the same mobile phase composition methanol with 0.1 % acetic acid and 0.1 % triethylamine (v/v). The flow rate was 1.0 mL min at ambient temperature (23 C).

P-Blockers, benzodiazepines, NSAIDs, barbiturates NSAIDs, protease inhibitors, P-blockers, benzodiazepines Antimalarials, NSAIDs, P-blockers, bronchodilators Phosphine oxides, NSAIDs, anticonvulsants Bronchodilators, P-blockers... 

Clinically used p-adrenergic receptor antagonists ( P-blockers ) are either px-selective (e.g. bisoprolol, metoprolol, atenolol, betaxolol) or non-selective,... 

By themselves, potassium-sparing agents are relatively weak antihypertensives. In general, there are four ways to reduce the activity of the RAS. The first way is the use of p-blockers to reduce renin release from the juxtaglomerular (JG). The second way, the direct inhibition of the activity of renin, although being actively investigated has not been successful in the clinical arena thus far. The third way is to inhibit the activity of the... 

Initiate diuretics and ACE inhibitors add digoxin, if symptoms persist add p blocker (when the patient is no longer overloaded with fluid)... 

Initiate ACE inhibitors add p blocker add diuretics and digoxin as needed for persistent or new symptoms... 

The results showed that the compounds studied with more frequency in the aquatic environment, and of which, logically, there is more information, are the antibiotics, analgesics and anti-inflammatories (like diclofenac, ibuprofen, naproxen, acetylsalicylic acid, and paracetamol), as well as the p-blocker atenolol. In the category of antibiotics, several families are included, like the macrolides (erythromycin), the fluoroquinolones (ofloxacin and ciprofloxacin), sulfonamides (sulfamethoxazole), penicillins (amoxicillin), the metronidazol, and trimethoprim. Other therapeutic groups also widely studied and frequently found in the environmental waters are the lipid regulators (gemfibrozil and bezafibrat), antiepileptic carbamaze-pine, and antidepressants (diazepam, fluoxetine, paroxetine) (see Table 3). 

Catecholamine Reserpine, propranolol, and other p blockers Placebo-controlled trial of reserpine had negative... 

Relative contraindications to the use of anticholinesterase treatment include a history of cardiovascular disease, asthma, glaucoma, and gastrointestinal or genitourinary obstruction. Symptomatic treatment of tachyarrhythmias with propranolol may be considered P blockers, however, are less effective than physostigmine. 

Fifteen -blockers have also been activated photochemically with the same radiation unit (Heraeus, Hanau Osram STE 501 UV lamp TNN 15-3200/721)[23]. Their detection limits, the working range and associated standard deviation of the method are listed in Table 1 below. The blue fluorescence of the chromatogram zones (Xg 5 = 313 nm, > 390 nm) was measured after dipping the chromatogram in liquid paraffin - n-hexane (1 + 2). Figure 18 illustrates the separation of seven P-blockers. 

The chromatograms are dried in a stream of warm air, sprayed homogeneously with spray solution I, dried briefly in a stream of hot air, then sprayed lightly with spray solution 2 and finally dried in a stream of warm air. In the case of P-blockers this is followed with a further light spray with spray solution 1 [5]. 

The detection limits for analeptics and stimulants are 2 to 5 pg substance per chromatogram zone [6]. P-Blockers can be detected at 50-100 ng per chromatogram zone [5]. 

P-Blockers yield yellow to pink-colored chromatogram zones on a colorless ba ground, which, like the zones of the ergot alkaloids and hydrogenated ergot alkalo can usually be exdted to blue fluorescence on irradiation with long-wavelength UV li (A, = 365 nm) [1, 3]. 

Summation (infection, stress, exercise, other allergen concomitant exposure, medication as P-blockers, NSAIDs, ACE inhibitors)... 

---